These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 20829049)
1. Expression of hepatocyte growth factor in the serum and cerebrospinal fluid of patients with Parkinson's disease. Salehi Z; Rajaei F J Clin Neurosci; 2010 Dec; 17(12):1553-6. PubMed ID: 20829049 [TBL] [Abstract][Full Text] [Related]
2. Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with Parkinson's disease. Mashayekhi F; Mirzajani E; Naji M; Azari M J Clin Neurosci; 2010 May; 17(5):623-7. PubMed ID: 20189394 [TBL] [Abstract][Full Text] [Related]
3. Brain-derived neurotrophic factor concentrations in the cerebrospinal fluid of patients with Parkinson's disease. Salehi Z; Mashayekhi F J Clin Neurosci; 2009 Jan; 16(1):90-3. PubMed ID: 19017558 [TBL] [Abstract][Full Text] [Related]
4. Concentrations of hepatocyte growth factor in cerebrospinal fluid under normal and different pathological conditions. Kern MA; Bamborschke S; Nekic M; Schubert D; Rydin C; Lindholm D; Schirmacher P Cytokine; 2001 May; 14(3):170-6. PubMed ID: 11396995 [TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor (HGF) in patients with hepatitis B and meningitis. Ozden M; Kalkan A; Demirdag K; Denk A; Kilic SS J Infect; 2004 Oct; 49(3):229-35. PubMed ID: 15337340 [TBL] [Abstract][Full Text] [Related]
6. Dynamic changes of hepatocyte growth factor in eosinophilic meningitis caused by Angiostrongylus cantonensis infection. Tsai HC; Huang YL; Liu YC; Wann SR; Lee SS; Chen ER; Yen CM; Tai MH; Shi MH; Chen YS Am J Trop Med Hyg; 2009 Jun; 80(6):980-2. PubMed ID: 19478261 [TBL] [Abstract][Full Text] [Related]
7. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma]. Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653 [TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor levels in cerebrospinal fluid: a comparison between acute bacterial and nonbacterial meningitis. Nayeri F; Nilsson I; Hagberg L; Brudin L; Roberg M; Söderström C; Forsberg P J Infect Dis; 2000 Jun; 181(6):2092-4. PubMed ID: 10837201 [TBL] [Abstract][Full Text] [Related]
10. Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells. Yukioka K; Inaba M; Furumitsu Y; Yukioka M; Nishino T; Goto H; Nishizawa Y; Morii H J Rheumatol; 1994 Dec; 21(12):2184-9. PubMed ID: 7699616 [TBL] [Abstract][Full Text] [Related]
11. Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue. Beppu K; Uchiyama A; Morisaki T; Nakamura K; Noshiro H; Matsumoto K; Nakamura T; Tanaka M; Katano M Anticancer Res; 2000; 20(2B):1263-7. PubMed ID: 10810432 [TBL] [Abstract][Full Text] [Related]
12. TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid. Vawter MP; Dillon-Carter O; Tourtellotte WW; Carvey P; Freed WJ Exp Neurol; 1996 Dec; 142(2):313-22. PubMed ID: 8934562 [TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of hepatocyte growth factor on human cord blood CD34+ progenitor cells are the result of c-met receptor expression. Goff JP; Shields DS; Petersen BE; Zajac VF; Michalopoulos GK; Greenberger JS Stem Cells; 1996 Sep; 14(5):592-602. PubMed ID: 8888500 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth. Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613 [TBL] [Abstract][Full Text] [Related]
15. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection. Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078 [TBL] [Abstract][Full Text] [Related]
16. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease. Briggs MC; Grierson I; Hiscott P; Hunt JA Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3085-94. PubMed ID: 10967068 [TBL] [Abstract][Full Text] [Related]
17. Prevention of onset of Parkinson's disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson's disease. Koike H; Ishida A; Shimamura M; Mizuno S; Nakamura T; Ogihara T; Kaneda Y; Morishita R Gene Ther; 2006 Dec; 13(23):1639-44. PubMed ID: 16791285 [TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease. Yang ZJ; Xu SL; Chen B; Zhang SL; Zhang YL; Wei W; Ma DC; Wang LS; Zhu TB; Li CJ; Wang H; Cao KJ; Gao W; Huang J; Ma WZ; Wu ZZ Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):790-6. PubMed ID: 19215239 [TBL] [Abstract][Full Text] [Related]
19. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma. Hu RH; Lee PH; Yu SC; Sheu JC; Lai MY Hepatogastroenterology; 1999; 46(27):1842-7. PubMed ID: 10430357 [TBL] [Abstract][Full Text] [Related]
20. Increased acidic fibroblast growth factor concentrations in the serum and cerebrospinal fluid of patients with Alzheimer's disease. Mashayekhi F; Hadavi M; Vaziri HR; Naji M J Clin Neurosci; 2010 Mar; 17(3):357-9. PubMed ID: 20079650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]